CareLit Fachartikel

Effect of Pridopidine in Huntington Disease (HD) Patients and Healthy Volunteers (HVs) – A Simultaneous Sigma-1 Receptor PET/Multimodality MRI Study

H Barthel, PM Meyer, M Rullmann, G Becker, M Bronzel, D Marsteller, O Voges, F Zientek, B Sattler, M Patt, E Strauss, A Kluge, JM Savola, MF Gordon, M Geva, S Hesse, M Hayden, ID Grachev, O Sabri · Nuklearmedizin - NuclearMedicine · 2020 · Heft 02

Dokument
1214933
CareLit-ID
Jahr
2020
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Nuklearmedizin - NuclearMedicine
Autor:innen
H Barthel, PM Meyer, M Rullmann, G Becker, M Bronzel, D Marsteller, O Voges, F Zientek, B Sattler, M Patt, E Strauss, A Kluge, JM Savola, MF Gordon, M Geva, S Hesse, M Hayden, ID Grachev, O Sabri
Ausgabe
Heft 02 / 2020
Jahrgang 59
Seiten
–
Erschienen: 2020-04-01 00:00:00
ISSN
0029-5566
DOI
10.1055/s-0040-1708414

Zusammenfassung

Effect of Pridopidine in Huntington Disease (HD) Patients and Healthy Volunteers (HVs) – A Simultaneous Sigma-1 Receptor PET/Multimodality MRI Study

Schlagworte

Effect Pridopidine Huntington Disease Patients Healthy Volunteers Simultaneous Sigma-1 Receptor Multimodality Study Nuklearmedizin - NuclearMedicine